Skip to content
  • Happy Health
  • Happy Mindset
  • Animal Wonders
  • About Us
    • Team
  • Subscribe
Menu
  • Happy Health
  • Happy Mindset
  • Animal Wonders
  • About Us
    • Team
  • Subscribe
Happy News

A Pill That Costs Pennies And Has Been Around For 125 Years May Also Fight Cancer

A pill that has been sitting in medicine cabinets for more than a century is showing signs of being far more powerful than anyone originally imagined, as a growing body of clinical evidence points to aspirin as a meaningful weapon against cancer. Researchers at the Karolinska Institute in Sweden tracked nearly 3,000 bowel cancer patients and found that those taking just 160mg of aspirin daily had less than half the risk of cancer recurrence compared to those on a placebo, results so striking that Sweden began screening bowel cancer patients for specific tumor mutations from January 2026 and offering low-dose aspirin to those who test positive. Scientists have identified two distinct biological mechanisms behind this: aspirin reduces inflammation that tumors exploit to grow and spread, and it blocks a clotting factor that suppresses the immune system’s ability to detect and destroy cancer cells, making tumors more visible to the body’s own defenses. Guidelines in the UK were already updated in 2020 to recommend aspirin for people with Lynch Syndrome from around age 20.

Now a much larger trial is underway to find out how far these effects extend. Led by Professor Ruth Langley at University College London, the study involves 11,000 participants across the UK, Ireland, and India who have previously had colorectal, breast, gastroesophageal, or prostate cancer, testing whether a daily low-dose aspirin can prevent recurrence across all four types, with results expected next year. Researchers are careful to note that aspirin carries real risks including internal bleeding and stomach ulcers, and stress that no one should start taking it for cancer prevention without speaking to a doctor first. But for a drug that costs pennies a day and has been in use for more than 125 years, the emerging evidence that it may also be one of the most broadly effective cancer-fighting tools ever discovered is a development the medical world is watching with very considerable excitement.

Source: https://www.bbc.co.uk/future/article/20260420-cancer-how-aspirin-may-be-a-powerful-new-weapon-against-tumours

PrevPreviousDoctors Just Gave 133 People Their Sight Back For Free

Recent Articles

Happy News

Jeopardy Contestant Is On A Historic Winning Streak

April 25, 2026

A 33-year-old law student and former bureaucrat from New Jersey named Jamie Ding has become one of the most exciting things happening on American television right now, racking up 28 consecutive wins on Jeopardy and earning over $730,000 in the process while steadily climbing toward one of the most storied

Read More
Happy News

A Soccer Club For Bereaved Dads Started With Two People And Has Just Won A National Award

April 25, 2026

When two bereaved fathers first showed up to kick a soccer ball around in Blackburn, England, the idea was simple: give men who had lost a child a place to come together through sport, something uncomplicated and human, where grief did not have to be explained or performed. That modest

Read More
Happy News

A Humanoid Robot Just Beat The Human World Record For The Half Marathon

April 25, 2026

On April 19th in Beijing, thousands of human runners competed in a half-marathon alongside more than 100 humanoid robots, and for the first time in history, a robot won. The champion was a self-navigating android called Lightning, developed by Chinese electronics company Honor, which completed the 13.1-mile course in 50

Read More
« Previous Next »
  • Privacy Notice
  • Accessibility Notice
  • Do Not Sell or Share My Personal Information
  • Unsubscribe
  • Terms and Conditions
  • Privacy Policy
  • Privacy Notice
  • Accessibility Notice
  • Do Not Sell or Share My Personal Information
  • Unsubscribe
  • Terms and Conditions
  • Privacy Policy
Copyright © 2026 HappyNews.